Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Chiasma Inc (Chiasma) is a clinical-stage bio pharmaceutical company. The company involves in development of oral medications for the treatment of rare and serious chronic diseases. It develops oral medications through its transient permeability enhancer (TPE) technology platform, which is designed to enable the development of oral forms of therapies. It clinical product candidate includes oral octreotide capsules, a novel formulation of octreotide which is in Phase 3 clinical trials intended for the treatment of adult patients with acromegaly. The company has operations in the US and Israel. Chiasma is headquartered in Waltham, Massachusetts, the US.
Headquarters
United States of America
Address
140 Kendrick Street, Building C East, Needham, Massachusetts, 02494
Website
www.chiasmapharma.com
Telephone
8 44 3042462
No of Employees
85
Industry
Pharmaceuticals and Healthcare
Revenue (2020)
$1.1M
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer